Recon: BioNTech, BMS tout positive Phase 2 readout for lung cancer; FDA OKs trial of gene-edited pig kidneys for transplantation
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States